Recent Advances in Non-Clear Cell Renal Cell Carcinoma Trials

This chapter discusses recent trials focusing on non-clear cell renal cell carcinoma, particularly the Sunny Forecast trial that evaluated the IPI-NEVO combination. It highlights the significant improvements in overall survival for patients receiving immunotherapy compared to standard care and explores additional therapeutic options for advanced RCC.